Archives of Disease in Childhood 2009;94:583-586
ORIGINAL ARTICLES
Treatment of acne with oral isotretinoin in patients with cystic fibrosis
1 Faculty of Medicine, University of Melbourne, Melbourne, Australia
2 Department of Respiratory Medicine, Royal Childrens Hospital, Melbourne, Australia
3 Department of Adolescent Medicine, Royal Childrens Hospital, Melbourne, Australia
Dr R Phillips, Paediatric Skin Specialist, Royal Childrens Hospital, Melbourne, Australia 3052; rod.phillips{at}rch.org.au
Background: Theoretical concerns about liver disease and vitamin A deficiency have limited the use of oral isotretinoin for troublesome acne in adolescents with cystic fibrosis.
Methods: Oral isotretinoin was administered to nine patients with cystic fibrosis who had troublesome acne unresponsive to antibiotics. All patients were followed for 1–4 years after cessation of treatment.
Results: Isotretinoin treatment cleared active acne lesions in all patients. It was well tolerated, and no patient had significant side effects. All nine patients were pleased or delighted with the improvement in their skin.
Conclusions: Adolescents with cystic fibrosis and acne can be treated with oral isotretinoin. Oral isotretinoin should be considered for adolescents with cystic fibrosis who have acne associated with scarring, acne not clearing with topical and antibiotic treatment, acne associated with depression or severe cystic acne.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



